WallStreetZenWallStreetZen

NASDAQ: SRPT
Sarepta Therapeutics Inc Stock Ownership - Who owns Sarepta Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sarepta Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Louise RodinoklapacPres2026-09-0421,423$22.22
$476.02kSell
Ryan Hoyan WongCFO2026-09-0413,272$22.22
$294.90kSell
Cristin RothfussCLO;EVP2026-09-0422,025$22.22
$489.40kSell
Ian Michael EstepanCOO2026-09-0424,799$22.22
$551.03kSell
Stephen MayoDirector2026-03-127,239$17.02
$123.21kSell
Ryan Hoyan WongChief Financial Officer2026-03-11256$17.03
$4.36kSell
Cristin RothfussEVP General Counsel2026-03-11974$17.03
$16.59kSell
Louise RodinoklapacPresident RD and Tech Ops2026-03-11948$17.03
$16.14kSell
Ian Michael EstepanChief Operating Officer2026-03-111,097$17.03
$18.68kSell
Louise RodinoklapacPresident RD and Tech Ops2026-03-09504$16.95
$8.54kSell

1 of 4

SRPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SRPT insiders and whales buy or sell their stock.

SRPT Shareholders

What type of owners hold Sarepta Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Black Bear Offshore Master Fund LP9.39%9,914,211$199.37MInsider
Eastbourne Capital Management LLC5.36%5,659,211$113.81MInsider
Richard Barry3.06%3,233,542$65.03MInsider
Rockall Emerging Markets Master Fund Ltd2.78%2,935,696$59.04MInsider
George Weaver Haywood2.30%2,426,953$48.81MInsider
Ryszard Kole1.76%1,862,926$37.46MInsider
Douglas S. Ingram0.88%929,391$18.69MInsider
Michael Severino0.72%756,104$15.21MInsider
Michael Andrew Chambers0.48%504,027$10.14MInsider
Leslie Hudson0.36%384,559$7.73MInsider

1 of 3

SRPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SRPT0.10%29.37%Net SellingNet Selling
TRVI0.09%99.91%Net BuyingNet Buying
URGN0.09%20.41%Net SellingNet Selling
PVLA0.10%42.89%Net SellingNet Selling
RXRX0.07%13.32%Net SellingNet Selling
View Top Biotech Stocks

Sarepta Therapeutics Stock Ownership FAQ

Who owns Sarepta Therapeutics?

Sarepta Therapeutics (NASDAQ: SRPT) is owned by 0.10% institutional shareholders, 29.37% Sarepta Therapeutics insiders, and 70.53% retail investors. Black Bear Offshore Master Fund LP is the largest individual Sarepta Therapeutics shareholder, owning 9.91M shares representing 9.39% of the company. Black Bear Offshore Master Fund LP's Sarepta Therapeutics shares are currently valued at $199.37M.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.